This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Persson, L.
Right arrow Articles by Rydén, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Persson, L.
Right arrow Articles by Rydén, C.

 Previous Article  |  Next Article 

Clinical and Vaccine Immunology, June 2009, p. 949-952, Vol. 16, No. 6
1071-412X/09/$08.00+0     doi:10.1128/CVI.00442-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Antibodies to Staphylococcus aureus Bone Sialoprotein-Binding Protein Indicate Infectious Osteomyelitis{triangledown}

Lena Persson,1,2 Christian Johansson,1,# and Cecilia Rydén1,2*

Department of Medical Biochemistry and Microbiology, Uppsala University BMC, Box 582, SE-75123 Uppsala, Sweden,1 Department of Infectious Diseases, Uppsala Academic Hospital, SE-75185 Uppsala, Sweden2

Received 13 November 2008/ Returned for modification 22 December 2008/ Accepted 6 April 2009

Discrimination of soft tissue infection from osteomyelitis in diabetic foot infections is a common clinical problem. Staphylococcus aureus isolates from patients with osteomyelitis express bone sialoprotein-binding protein (Bbp) that binds the bone matrix protein bone sialoprotein. The serological assay with Bbp discriminated cases of osteomyelitis from soft tissue infections in patients with diabetic foot ulcers.

* Corresponding author. Mailing address: Departments of Medical Biochemistry and Microbiology/Medical Sciences, Uppsala University BMC, Box 582, S-751 23 Uppsala, Sweden. Phone: 46-18-471 4234. Fax: 46-18-471 4673. E-mail: Cecilia.Ryden{at}imbim.uu.se

{triangledown} Published ahead of print on 15 April 2009.

# Present address: Department of Neurology, Södersjukhuset, Stockholm, Sweden.

Clinical and Vaccine Immunology, June 2009, p. 949-952, Vol. 16, No. 6
1071-412X/09/$08.00+0     doi:10.1128/CVI.00442-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.





Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»